Phase 1 Single Ascending Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of KBP-5074
Clinical trial NCT02228733 · COMPLETED
Trial details
- NCT number
- NCT02228733
- Sponsor
- KBP Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2015-01-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.